Donepezil: Difference between revisions
David Canner (talk | contribs) No edit summary |
David Canner (talk | contribs) No edit summary |
||
| Line 2: | Line 2: | ||
===Better Known as: Aricept=== | ===Better Known as: Aricept=== | ||
* Marketed By: Eisai & Pfizer <br /> | * Marketed By: Eisai & Pfizer <br /> | ||
* Major Indication: Alzheimer's Disease<br /> | * Major Indication: [[Alzheimer's Disease]]<br /> | ||
* Drug Class: [[Acetylcholinesterase]] Inhibitor | * Drug Class: [[Acetylcholinesterase]] Inhibitor | ||
* Date of FDA Approval (Patent Expiration): 1996 (2008)<br /> | * Date of FDA Approval (Patent Expiration): 1996 (2008)<br /> | ||